Cargando…
CRISPR based therapeutics: a new paradigm in cancer precision medicine
BACKGROUND: Clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated protein (Cas) systems are the latest addition to the plethora of gene-editing tools. These systems have been repurposed from their natural counterparts by means of both guide RNA and Cas nuclease engineer...
Autores principales: | Das, Sumit, Bano, Shehnaz, Kapse, Prachi, Kundu, Gopal C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953071/ https://www.ncbi.nlm.nih.gov/pubmed/35337340 http://dx.doi.org/10.1186/s12943-022-01552-6 |
Ejemplares similares
-
Therapeutic implications of cancer stem cells in prostate cancer
por: Banerjee, Pinaki, et al.
Publicado: (2023) -
Precision Medicine: A New Paradigm in Therapeutics
por: Akhoon, Neha
Publicado: (2021) -
Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics
por: Gavriilaki, Maria, et al.
Publicado: (2020) -
Changing paradigm of cancer therapy: precision medicine by next-generation sequencing
por: Xue, Yuan, et al.
Publicado: (2016) -
Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
por: Butti, Ramesh, et al.
Publicado: (2018)